Cabaletta Bio, Inc. (CABA)
USD 2.29
(-16.73%)
USD 2.29
(-16.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -53.54 Million | -46.38 Million | -34.1 Million | -26.77 Million | -16.04 Million | -4.66 Million |
| Net Income | -67.67 Million | -52.97 Million | -46.28 Million | -33.33 Million | -16.94 Million | -12.2 Million |
| Depreciation & Amortization | 1.42 Million | 1.17 Million | 733 Thousand | 354 Thousand | 104 Thousand | - |
| Deferred income taxes | -1.67 Million | - | - | - | -2.26 Million | - |
| Stock-based compensation | 11.34 Million | 6.89 Million | 5.8 Million | 4.38 Million | 2.3 Million | 606 Thousand |
| Change in working capital | 101 Thousand | -4.29 Million | 5.58 Million | 1.7 Million | -1.5 Million | -464 Thousand |
| Other non-cash items | 2.93 Million | 2.81 Million | 62 Thousand | 119 Thousand | 2.26 Million | 7.39 Million |
| Investing Cash Flow | -22.45 Million | -27.21 Million | 5.99 Million | -7.98 Million | -693 Thousand | - |
| Investments in PPE | -687 Thousand | -2.45 Million | -1.16 Million | -635 Thousand | -693 Thousand | - |
| Acquisitions | 21.76 Thousand | 24.76 Thousand | - | 7346.00 | - | - |
| Investment purchases | -84.26 Million | -49.76 Million | - | -11.09 Million | - | - |
| Sales/Maturities of investments | 62.5 Million | 25 Million | 7.16 Million | 3.75 Million | - | - |
| Other Investing Activities | -21.76 Thousand | -24.76 Thousand | 7165.00 | -7346.00 | - | - |
| Financing Cash Flow | 187.63 Million | 32.98 Million | 48.9 Million | -24 Thousand | 119.92 Million | 37.67 Million |
| Debt repayment | - | - | - | - | -10.09 Million | -12.53 Million |
| Dividends payments | - | - | - | - | -10.09 Million | - |
| Common Stock Repurchased | 108 Thousand | 76 Thousand | 71 Thousand | -192 Thousand | -1.29 Million | -169 Thousand |
| Common Stock Issuance | 187.63 Million | 32.98 Million | 48.9 Million | 29 Thousand | 71.21 Million | 25.14 Million |
| Other Financing Activities | 187.63 Million | 32.98 Million | 48.9 Million | 139 Thousand | 70.18 Million | 37.84 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.67 Million | -28 Thousand | 975 Thousand | 555 Thousand | 246 Thousand | 234 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.57 Million | -4.27 Million | 4.6 Million | 1.15 Million | -1.75 Million | -698 Thousand |
| Cash at beginning of period | 81.6 Million | 122.22 Million | 101.42 Million | 136.2 Million | 33.01 Million | 1000.00 |
| Cash at end of period | 193.23 Million | 81.6 Million | 122.22 Million | 101.42 Million | 136.2 Million | 33.01 Million |
| Capital Expenditure | -687 Thousand | -2.45 Million | -1.16 Million | -635 Thousand | -693 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 111.63 Million | -40.61 Million | 20.79 Million | -34.77 Million | 103.18 Million | 33.01 Million |
| Free Cash Flow | -54.23 Million | -48.83 Million | -35.27 Million | -27.4 Million | -16.73 Million | -4.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -27.6 Million | -25.04 Million | -20.88 Million | -67.67 Million | -16.44 Million | -14.48 Million |
| Depreciation & Amortization | 426 Thousand | 393 Thousand | 336 Thousand | 1.42 Million | 355 Thousand | 370 Thousand |
| Deferred income taxes | - | - | -3.2 Million | -1.67 Million | -653 Thousand | -173 Thousand |
| Stock-based compensation | 5.01 Million | 3.79 Million | 3.05 Million | 11.34 Million | 3 Million | 2.8 Million |
| Change in working capital | -31 Thousand | -4.13 Million | 654 Thousand | 101 Thousand | 548 Thousand | -959 Thousand |
| Other non-cash items | 8.6 Million | 3.92 Million | 3.6 Million | 2.93 Million | 585 Thousand | 557 Thousand |
| Investing Cash Flow | 23.73 Million | -812 Thousand | 1.13 Million | -22.45 Million | -65 Thousand | -48.14 Million |
| Investments in PPE | -770 Thousand | -812 Thousand | -185 Thousand | -687 Thousand | -65 Thousand | -57 Thousand |
| Acquisitions | - | - | -1321.00 | 21.76 Thousand | - | - |
| Investment purchases | - | - | -36.17 Million | -84.26 Million | - | -48.08 Million |
| Sales/Maturities of investments | 24.5 Million | - | 37.5 Million | 62.5 Million | - | - |
| Other Investing Activities | 24.5 Million | - | 1321.00 | -21.76 Thousand | - | -48.08 Thousand |
| Financing Cash Flow | 379 Thousand | 6.85 Million | 93.04 Million | 187.63 Million | 98 Thousand | 94.25 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 340 Thousand | 108 Thousand | - | - |
| Common Stock Issuance | 379 Thousand | 1.1 Million | 93.04 Million | 187.63 Million | 98 Thousand | 94.02 Million |
| Other Financing Activities | 379 Thousand | 5.74 Million | 93.04 Thousand | 187.63 Million | 98.00 | 232 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.33 Million | 1.65 Million | 518 Thousand | 1.67 Million | 1.3 Million | -1.86 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.3 Million | -5.78 Million | 136 Thousand | -1.57 Million | -754 Thousand | 910 Thousand |
| Cash at beginning of period | 175.29 Million | 193.23 Million | 115.5 Million | 81.6 Million | 128.07 Million | 93.84 Million |
| Cash at end of period | 178.61 Million | 175.29 Million | 193.23 Million | 193.23 Million | 115.5 Million | 128.07 Million |
| Capital Expenditure | -770 Thousand | -812 Thousand | -185 Thousand | -687 Thousand | -65 Thousand | -57 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.32 Million | -17.94 Million | 77.73 Million | 111.63 Million | -12.57 Million | 34.22 Million |
| Free Cash Flow | -21.55 Million | -24.8 Million | -16.63 Million | -54.23 Million | -12.66 Million | -11.94 Million |
EBYH
AIRYY
5255
140410
6835
AQN